Connect with us

Politics

DEA Head Slammed Over Marijuana Stance By Lawmakers

Published

on

The acting administrator of the Drug Enforcement Administration (DEA) was put through the wringer by lawmakers on Capitol Hill on Tuesday, pressed repeatedly to answer questions about the federal agency’s outdated marijuana policy.

Here’s a roundup of exchanges between DEA Acting Administrator Robert Patterson and members of the House Judiciary Committee during a hearing on the opioid epidemic.

Rep. Steve Cohen (D-TN) 

“The DEA has always been in a position of great importance—and it’s important that the DEA administrator stay current with what the people have shown by their actions and their statements what they believe is the right priorities for the DEA,” Cohen started.

In short, the people don’t think marijuana should be a federal law enforcement priority, he said. He then asked Patterson why marijuana is classified in the same drug scheduling category as more harmful drugs such as heroin.

“The reason why it remains in Schedule I is the science,” Patterson said.

“The science?” Cohen responded. He later added, “I’m happy to hear that you believe in science, that’s refreshing.” But Cohen wanted to know what the DEA official’s personal views on marijuana scheduling were, and Patterson delivered: He said that he was worried the country was “going down a bad path with marijuana” and that all of the national conversations around reform mainly had to do with revenue.

Cohen pushed back, arguing that adults also care about racially disproportionate arrests for non-violent marijuana offenses, for instance. Patterson said he didn’t see a link between prohibitionist marijuana policies and mass incarceration, then went into a rant that concluded:

“At what point did we determine that revenue was more important than our kids?”

Rep. Hank Johnson (D-GA)

Johnson began his questioning by asking Patterson how many Americans died from opioid-related overdoses among the 64,000 drug overdose deaths recorded in 2016.

Patterson knew that figure, responding that about 44,000 deaths were the result of opioid-related overdoses. But when asked a follow-up question about marijuana-related overdose deaths, the DEA official said that he didn’t believe there were any officially recorded in 2016, but that he was “aware of a few deaths from marijuana.”

(The DEA itself said there were no known deaths attributed to a marijuana overdose in a 2017 report on drug abuse.)

“You are aware of a few deaths from marijuana?” Johnson asked. At that point, Patterson said that he didn’t have materials in front of him to reference, but that he believed these deaths were caused by “adulterated” cannabis and said he ultimately understood the congressman’s point: that in terms of risk of overdose, marijuana and opioids are “not comparable.”

Rep. Eric Swalwell (D-CA)

Swalwell used his time at the hearing to talk about the struggles of families he’s met whose children have either fatally overdosed on opioids or suffered from addiction. He asked Patterson what can be done to prevent and address youth substance abuse.

The DEA official discussed the importance of early education drug prevention programs—and then pivoted to marijuana.

“I hate to do this, but I’m going to do it to you—and this is what concerns me about marijuana because those same stories I hear all the time, I generally hear marijuana introduced,” Patterson said. But he then made a surprising admission, telling Swalwell that he’s “not going to compare” drugs like marijuana and opioids, and also that he wouldn’t “say [marijuana is] a gateway [drug].”

That caveat was significant, Don Murphy, director of conservative outreach at the Marijuana Policy Project, said in a statement to Marijuana Moment. “When the head of the DEA rejects the gateway theory, he’s a witness for an end to prohibition,” Murphy said. 

Patterson did go on to say that “the problem is that these things all seem to dovetail together, and my concern is—and again, I’ll take my DEA hat off for a second is as a person in the United States—what message we send as we try to navigate this space in terms of that, and I think that’s problematic.”

Rep. Matt Gaetz (R-FL)

Gaetz wanted to know whether it is “the position of the DEA that democratizing access to medical marijuana will add to the substance abuse problem in this country.” Patterson said he feels “it’s a conversation that we have to have.”

But that question appeared to set Gaetz up for an extensive back-and-forth during which the DEA head demonstrated a stunning lack of knowledge about the existing scientific literature concerning marijuana’s health benefits and its potential use as a substitute for dangerous pharmaceuticals, including opioid painkillers.

Was Patterson familiar with a 2017 report from the National Academies of Science that found “conclusive or substantial evidence” that cannabis and cannabinoids effectively treats chronic pain—a condition that is traditionally treated with opioid painkillers? No.

Was he familiar any of the numerous patient surveys from states where marijuana has been legalized, showing significant reductions in pharmaceutical use correlated with cannabis reform? No.

OK, was he aware of any studies that showed the opposite? That marijuana use was associated with increased use of dangerous illicit drugs? Again, no.

So then, going back to his first question, why is it that the DEA cannot speak to its official position as to whether marijuana legalization would add to the country’s substance abuse problem if its acting administrator can’t defend that argument based on any “evidentiary standpoint,” Gaetz asked. A flustered Patterson reaffirmed the agency’s support for research into medical marijuana and also pinned blame on the lack of DEA-approved research grants for medical marijuana research on international treaties that he claimed were being deliberated by the Justice Department.

Gaetz said he appreciated the agency’s support for research and asked whether the DEA would commit to partnering with lawmakers in their efforts to expand federal marijuana research.

“We’ve been consistent in that message,” Patterson said.

Marijuana Kills People, DEA Claims

Photo courtesy of Ted Eytan.

If you value staying updated on cannabis news, please start a monthly Patreon pledge to support Marijuana Moment!

Kyle Jaeger is an LA-based contributor to Marijuana Moment. His work has also appeared in High Times, VICE, and attn.

Politics

Voters In Key Congressional Districts Support Marijuana Legalization, Poll Says

Published

on

With many key congressional races rated as “toss ups” by political observers, either major party could end up controlling of the U.S. House of Representatives after this November’s midterm elections.

A new poll identifies one thing that can help Republican or Democratic candidates come out ahead: Embracing marijuana legalization.

The polling firm Lake Research Partners surveyed 800 likely 2018 general election voters in 60 so-called “battleground districts,” finding that 60 percent support ending cannabis prohibition. Only 36 percent are opposed.

Medical marijuana is even more popular, with 79 percent of voters in these swing districts on board.

More to the point for politicians looking to win elections, the survey showed that 44 percent of battleground voters say they would be more more likely to vote for a candidate who supports legalization, including 26 percent who say they would be “much” more likely. Only 33 percent said they would be less likely to back a pro-legalization candidate.

The survey was conducted in February but is being released on Tuesday at Washington, D.C. event sponsored by MedMen Enterprises, a cannabis dispensary chain that commissioned the poll.

Another key finding is that 55 percent of voters say they would be “more likely” to vote if a marijuana initiative was on the ballot in their state.

The survey also tested the effectiveness of various arguments concerning legalization, determining that “the strongest pro-legalization message frame highlights how we need legalization to repair the financial and moral damage of the failed war on drugs,” according to a polling memo prepared by the firm.

Several other recent national polls have found majority support for marijuana legalization, but the new results narrowed down to key swing districts are likely to warrant special attention from candidates and political operatives.

Support for Marijuana Legalization At Record High, New Survey Shows

Photo courtesy of Chris Wallis // Side Pocket Images.

If you value staying updated on cannabis news, please start a monthly Patreon pledge to support Marijuana Moment!
Continue Reading

Politics

Congressional Committee Blocks Marijuana Votes (Again)

Published

on

Lawmakers on a key congressional committee once again blocked colleagues in the full House from being able to vote on marijuana-related amendments.

One proposed measure, filed last week, would have allowed Washington, D.C. to legally tax and regulate retail marijuana sales and another would have prevented federal regulators from penalizing federal banks from working with businesses and individuals in the legal cannabis industry.

But on Monday evening, the Republican-controlled Rules Committee, led by Congressman Pete Sessions (R-TX), continued its recent tradition of preventing floor votes on any and all measures to scale back federal cannabis prohibition.

“Everyone who knows that Congress has a responsibility to at least debate these issues should unite and help Pete Sessions find another line of work,” Congressman Earl Blumenauer (D-OR), who cosponsored both cannabis measures, told Marijuana Moment in a statement.

Sessions’s Texas district, which Hillary Clinton won in 2016, is currently considered a “toss up” by political analysts in this November’s midterm elections.

Before Monday, his panel had blocked at least 34 other cannabis-related amendments from reaching the floor for votes during the current Congress. The full House of Representatives has not been allowed to consider marijuana reform proposals since the spring of 2016.

Analysis: GOP Congress Has Blocked Dozens Of Marijuana Amendments

Bipartisan groups of lawmakers cosponsored both new cannabis measures, which they were seeking to attach to legislation to fund parts of the federal government through Fiscal Year 2019.

(A third marijuana-related measure considered on Monday proposes shifting money away from forest and rangeland research toward “eradicating, enforcing, and remediating illegal marijuana grow operations on National Forest System land.” That measure was cleared for a floor vote, likely sometime this week.)

“Our federal laws are outdated. The people in this country want the law to treat marijuana as we do alcohol,” Congressman Denny Heck (D-WA), said in testimony about his marijuana banking amendment. “These large sums of cash make dispensaries an obvious target for robberies.”

He recounted the story of Travis Mason, a 24-year-old Marine veteran who was killed during a 2016 robbery at a Colorado marijuana dispensary where he was serving as a security guard.

“He managed to survive his service in the United States Marine Corps, but he didn’t survive his job guarding a store here at home,” Heck said.

“If we do nothing, this is bound to happen again.”

The D.C. measure was filed by Democratic Congresswoman Eleanor Holmes Norton, who represents the District of Columbia.

“This rider has unintentionally benefited violent drug gangs,” Norton said of current policy in her testimony before the Rules Committee. “For that reason, some refer to it as the ‘Drug Dealer Protection Act.’ As one marijuana dealer told the Washington Post, the rider is ‘a license for me to print money.’ Regulating marijuana like alcohol would allow D.C., instead of drug dealers, to control production, distribution, sales and revenues.”

Under a ballot measure approved by D.C. voters in 2014, low-level marijuana possession and home cultivation is legal. But because of an ongoing federal appropriations rider enacted in past years and included in the new FY19 bill, local officials have been prevented from adding a system of taxed and regulated cannabis sales.

Congressman Jared Polis (D-CO), a member of the Rules Committee, specifically moved during the meeting Monday night to make the amendment on cannabis businesses’ access to banks in order for a floor vote, but that was defeated by a party-line vote of 8 – 2.

The marijuana banking measure had 22 cosponsors, more than any of the 276 other measures the Rules Committee considered this week. Eighty-seven amendments were cleared for floor consideration.

Congress Could Vote On These Marijuana Amendments Next Week (Unless GOP Blocks Them Again)

If you value staying updated on cannabis news, please start a monthly Patreon pledge to support Marijuana Moment!
Continue Reading

Business

Sen. Jeff Merkley “Disappointed” That Democrats Blocked His Marijuana Banking Amendment

Published

on

One of the U.S. Senate’s foremost champions for marijuana law reform says he is “disappointed” that fellow Democrats recently joined with Republicans in blocking his amendment to increase cannabis businesses’ access to banks.

Last month, Sen. Jeff Merkley (D-OR) offered a measure that would have shielded banks that open accounts for state-legal marijuana businesses from being punished by federal regulators for that activity even though cannabis remains illegal under federal law.

While the Senate Appropriations Committee had approved two similar amendments in previous years, the panel this time voted to table the measure with a bipartisan vote of 21 – 10, with ranking member Sen. Patrick Leahy (D-VT) and other Democrats who normally support marijuana reform objecting on procedural grounds.

“I was disappointed,” Merkley said in an interview with BuzzFeed editor Ben Smith on Monday. “We had passed this twice before.”

“We need to establish banking for cannabis because a cash economy is an invitation to money laundering and theft and cheating your employees and cheating on your taxes [and] organized crime. All bad.”

“I accompanied the owner of a company who had $70,000 in his backpack to pay quarterly taxes,” Merkley recounted in response to the cannabis banking question on Monday, which was suggested to BuzzFeed by Marijuana Moment’s editor. “It’s so bizarre going down the freeway and talking about how they have to pay their employees in cash, have to pay their suppliers in cash. It’s a bad system.”

“Everyone should agree: States’ rights on this. Let the states have an electronic system to track what these businesses are doing, not billions of dollars floating around like this.”

Despite his disappointment with the measure being blocked, the Oregon Democrat, who is believed to be considering a 2020 presidential run, said that his colleagues “had a fair point to make on the policy front” in tabling the measure.

At the time, Leahy argued that spending bills such as the one before the committee should be kept “free of new controversial policy riders” and that a more appropriate forum would be an authorizing committee that sets banking laws.

“It wasn’t existing policy and therefore it was new policy,” Merkley acknowledged in the new interview.

But he pointed out that there are few other avenues available for senators to pursue the issue.

“Here’s the thing. Normally we could take these policy bills like I was putting forward [and] you could put it on the floor of the Senate as an amendment to something,” he said. “In 2017, outside of the budget process, not a single amendment was considered on the floor of the Senate… This is the end of the Senate really as a deliberative body on policy. So if you’re blocked in the Appropriations Committee, and you’re blocked on the floor, then it’s very hard to put ideas out there and say, ‘Hey vote on this. This matters.'”

The House Appropriations Committee also defeated a cannabis banking amendment last month.

See the video of Merkley’s remarks at about 19:15 into the clip below:

Photo courtesy of Senate Democrats.

If you value staying updated on cannabis news, please start a monthly Patreon pledge to support Marijuana Moment!
Continue Reading
Advertisement

Stay Up To The Moment

Marijuana News In Your Inbox


Support Marijuana Moment

Marijuana News In Your Inbox